Journal of the National Cancer Institute (JNCI) |
BRCA1 and BRCA2 Gene Mutations and Colorectal Cancer Risk: Systematic Review and Meta-analysis |
nov. 18 |
1 ♥ |
Cancer colorectal (CCR) |
Journal of the National Cancer Institute (JNCI) |
Celecoxib for the Prevention of Colorectal Adenomas: Results of a Suspended Randomized Controlled Trial |
aoû. 16 |
2 ♥ |
Cancer colorectal (CCR) |
Journal of the National Cancer Institute (JNCI) |
Effects of Nutrition Intervention on Total and Cancer Mortality: 25-Year Post-trial Follow-up of the 5.25-Year Linxian Nutrition Intervention Trial |
nov. 18 |
1 ♥ |
Cancer colorectal (CCR) |
Journal of the National Cancer Institute (JNCI) |
Selenium Supplementation for Prevention of Colorectal Adenomas and Risk of Associated Type 2 Diabetes |
aoû. 16 |
1 ♥ |
Cancer colorectal (CCR) |
Journal of the National Cancer Institute (JNCI) |
Prognostic Value of BRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer |
mai. 17 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Annual Medical Expenditure and Productivity Loss Among Colorectal, Female Breast, and Prostate Cancer Survivors in the United States |
mai. 16 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
The Heterogeneity Between Lynch-Associated and Sporadic MMR Deficiency in Colorectal Cancers |
sep. 18 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Long-term Outcome of an Organ Preservation Program After Neoadjuvant Treatment for Rectal Cancer |
aoû. 16 |
2 ♥ |
Cancer colorectal (CCR) |
Journal of the National Cancer Institute (JNCI) |
Influence of Statins and Cholesterol on Mortality Among Patients With Pancreatic Cancer |
mai. 17 |
1 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
A Plasma Biomarker Panel to Identify Surgically Resectable Early-Stage Pancreatic Cancer |
aoû. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Relevance of Sp Binding Site Polymorphism in WWOX for Treatment Outcome in Pancreatic Cancer |
mai. 16 |
2 ♥ |
Cancers autres (hors CCR et CHC), Pancréas/Voies biliaires |
Journal of the National Cancer Institute (JNCI) |
Risk of Different Cancers Among First-degree Relatives of Pancreatic Cancer Patients: Influence of Probands’ Susceptibility Gene Mutation Status |
mar. 19 |
4 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Tumour-stroma ratio and prognosis in gastric adenocarcinoma |
aoû. 18 |
1 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours |
mar. 19 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Quality-adjusted survival with combination nal-IRI+5-FU/LV vs 5-FU/LV alone in metastatic pancreatic cancer patients previously treated with gemcitabine-based therapy: a Q-TWiST analysis |
mai. 17 |
1 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Long-term outcomes of patients with 10 or more colorectal liver metastases |
aoû. 17 |
2 ♥ |
Cancer colorectal (CCR) |
British journal of Cancer |
The value of using the faecal immunochemical test in general practice on patients presenting with non-alarm symptoms of colorectal cancer |
aoû. 18 |
1 ♥ |
Cancer colorectal (CCR) |
British journal of Cancer |
Long-term results and recurrence patterns from SCALOP: a phase II randomised trial of gemcitabine- or capecitabine-based chemoradiation for locally advanced pancreatic cancer |
mai. 17 |
1 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Body weight trajectories and risk of oesophageal and gastric cardia adenocarcinomas: a pooled analysis of NIH-AARP and PLCO Studies |
mar. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Molecular profiling of neuroendocrine malignancies to identify prognostic and therapeutic markers: a Fox Chase Cancer Center Pilot Study |
aoû. 16 |
1 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Phase III randomised trial comparing 6 vs. 12-month of capecitabine as adjuvant chemotherapy for patients with stage III colon cancer: final results of the JFMC37-0801 study |
avr. 19 |
1 ♥ |
Cancer colorectal (CCR) |
British journal of Cancer |
Serum LDH predicts benefit from bevacizumab beyond progression in metastatic colorectal cancer |
Jan. 17 |
2 ♥ |
Cancer colorectal |
British journal of Cancer |
Gemcitabine plus platinum-based chemotherapy for first-line treatment of hepatocholangiocarcinoma: an AGEO French multicentre retrospective study. |
fév. 18 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Patterns of progression, treatment of progressive disease and post-progression survival in the New EPOC study |
aoû. 16 |
1 ♥ |
Cancer colorectal (CCR) |
British journal of Cancer |
Can we classify ampullary tumours better? Clinical, pathological and molecular features. Results of an AGEO study |
avr. 19 |
2 ♥ |
Cancers autres (hors CCR et CHC) |